Maintenance Therapy in Nonsmall-Cell Lung Cancer: A New Treatment ParadigmMOK, Tony S. K; RAMALINGAM, Suresh S.Cancer. 2009, Vol 115, Num 22, pp 5143-5154, issn 0008-543X, 12 p.Article

ALK-Positive Non-Small Cell Lung Cancer: Mechanisms of Resistance and Emerging Treatment OptionsSTEUER, Conor E; RAMALINGAM, Suresh S.Cancer. 2014, Vol 120, Num 16, pp 2392-2402, issn 0008-543X, 11 p.Article

Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging ConsensusOWONIKOKO, Taofeek K; RAMALINGAM, Suresh S; BELANI, Chandra P et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2496-2504, issn 1078-0432, 9 p.Article

Retinoic Acid Enhances TRAIL-Induced Apoptosis in Cancer Cells by Upregulating TRAIL Receptor 1 ExpressionDHANDAPANI, Latha; PING YUE; RAMALINGAM, Suresh S et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 15, pp 5245-5254, issn 0008-5472, 10 p.Article

Phase 2 Study of Irinotecan and Paclitaxel in Patients With Recurrent or Refractory Small Cell Lung CancerRAMALINGAM, Suresh S; FOSTER, Judy; GOODING, William et al.Cancer. 2010, Vol 116, Num 5, pp 1344-1349, issn 0008-543X, 6 p.Article

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium StudyCHAO, Joseph; SYNOLD, Timothy W; BELANI, Chandra P et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 835-843, issn 0344-5704, 9 p.Article

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung CancerRAMALINGAM, Suresh S; SPIGEL, David R; LIAN LIU et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4574-4580, issn 0732-183X, 7 p.Article

Outcomes for Elderly, Advanced-Stage Non-Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel : Analysis of Eastern Cooperative Oncology Group Trial 4599RAMALINGAM, Suresh S; DAHLBERG, Suzanne E; LANGER, Corey J et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 60-65, issn 0732-183X, 6 p.Article

E5501: phase II study of topotecan sequenced with etoposide/ cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancerOWONIKOKO, Taofeek K; AISNER, Joseph; XIN VICTORIA WANG et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 171-180, issn 0344-5704, 10 p.Article

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRUDIN, Charles M; HANN, Christine L; RANSON, Malcolm R et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, issn 1078-0432, 7 p.Article

Farnesyl Transferase Expression Determines Clinical Response to the Docetaxel-Lonafarnib Combination in Patients With Advanced MalignanciesKAUH, John; CHANEL-VOS, Chantal; RAMALINGAM, Suresh S et al.Cancer. 2011, Vol 117, Num 17, pp 4049-4059, issn 0008-543X, 11 p.Article

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid TumorsRAMANATHAN, Ramesh K; EGORIN, Merrill J; ERLICHMAN, Charles et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1520-1526, issn 0732-183X, 7 p.Article

Bcl2 Induces DNA Replication Stress by Inhibiting Ribonucleotide ReductaseMAOHUA XIE; YUN YEN; OWONIKOKO, Taofeek K et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 1, pp 212-223, issn 0008-5472, 12 p.Article

Phase 1 and Pharmacokinetic Study of Everolimus in Combination With Cetuximab and Carboplatin for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckSABA, Nabil F; HURWITZ, Selwyn J; KONO, Scott A et al.Cancer. 2014, Vol 120, Num 24, pp 3940-3951, issn 0008-543X, 12 p.Article

Effect of Prophylactic Cranial Irradiation on Survival in Elderly Patients With Limited-Stage Small Cell Lung CancerEATON, Bree R; KIM, Sungjin; MARCUS, David M et al.Cancer. 2013, Vol 119, Num 21, pp 3753-3760, issn 0008-543X, 8 p.Article

Soluble FAS Ligand as a Biomarker of Disease Recurrence in Differentiated Thyroid CancerOWONIKOKO, Taofeek K; HOSSAIN, Mohammad S; BHIMANI, Chandar et al.Cancer. 2013, Vol 119, Num 8, pp 1503-1511, issn 0008-543X, 9 p.Article

Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): A systematic reviewBEHERA, Madhusmita; OWONIKOKO, Taofeek K; SUNGJIN KIM et al.Oral oncology (1997). 2014, Vol 50, Num 9, pp 888-894, issn 1368-8375, 7 p.Article

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan―Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; BLACKHALL, Fiona; LETRENT, Stephen P et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3337-3344, issn 0732-183X, 8 p.Article

Phase 1 and Pharmacokinetic Study of Everolimus, a Mammalian Target of Rapamycin Inhibitor, in Combination With Docetaxel for Recurrent/Refractory Nonsmall Cell Lung CancerRAMALINGAM, Suresh S; HARVEY, R. Donald; HAIAN FU et al.Cancer. 2010, Vol 116, Num 16, pp 3903-3909, issn 0008-543X, 7 p.Article

Class I HDACs Are Mediators of Smoke Carcinogen-Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung CancerBRODIE, Seth A; GE LI; VERTINO, Paula M et al.Cancer prevention research (Philadelphia, Pa.). 2014, Vol 7, Num 3, pp 351-361, issn 1940-6207, 11 p.Article

Long-Term Use of Valproic Acid in US Veterans Is Associated With a Reduced Risk of Smoking-Related Cases of Head and Neck CancerHYUNSEOK KANG; GILLESPIE, Theresa W; GOODMAN, Michael et al.Cancer. 2014, Vol 120, Num 9, pp 1394-1400, issn 0008-543X, 7 p.Article

Human Immunodeficiency Virus-Associated Lung Cancer in the Era of Highly Active Antiretroviral TherapyPAKKALA, Suchita; ZHENGJIA CHEN; RAMALINGAM, Suresh S et al.Cancer. 2012, Vol 118, Num 1, pp 164-172, issn 0008-543X, 9 p.Article

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; MAITLAND, Michael L; BELANI, Chandra P et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 56-62, issn 0732-183X, 7 p.Article

A Phase I Study of17-Allylamino-17-Demethoxygeldanamycin Combined with Paclitaxel in Patients with Advanced Solid MalignanciesRAMALINGAM, Suresh S; EGORIN, Merrill J; IVY, S. Percy et al.Clinical cancer research. 2008, Vol 14, Num 11, pp 3456-3461, issn 1078-0432, 6 p.Article

Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignanciesRAMALINGAM, Suresh S; PARISE, Robert A; BELANI, Chandra P et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3605-3610, issn 1078-0432, 6 p.Article